Answers are grounded in this paper and cite their sources.
Retrospective study highlights delayed diagnosis and high prevalence of HER2-positive tumors in male breast cancer, suggesting urgent need for awareness and targeted therapies.
MBC in this cohort was characterized by delayed diagnosis, advanced presentation, and a high prevalence of HER2-positive tumors. Multimodality, biomarker-guided therapy achieved durable control in many patients, underscoring the urgent need for awareness initiatives, earlier detection, and equitable access to targeted therapies in India.
No takes yet. Share an insight, caveat, or question.
Potu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: